Findings

What do systematic reviews say?

67 questions · 69 findings · 8 reviews

No studies found 19 · 27.5%GRADE not reported 7 · 10.1%Very low 19 · 27.5%Low 7 · 10.1%Moderate 12 · 17.4%High 5 · 7.2%

Radiological failure · Children with extensive decay involving the dental pulp in primary teeth

1 finding from 1 review

Pulp treatment for extensive decay in primary teeth 2018 · Cochrane All outcomes
12 months
No radiological failure in any participant (Aminabadi 2016); not estimable
1 study · 160 participants
GRADE not reported

Duration of diarrhoea · Adults and children with cholera diarrhoea

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 375 participants
Moderate

Stool volume · Adults and children with cholera diarrhoea

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
no estimate extracted
1 study · 195 participants
Low

Bacteriological failure · Adults and children with cholera diarrhoea

Azithromycin may leads to lower bacteriological failure compared with ciprofloxacin (low certainty).

1 finding from 1 review

Antimicrobial drugs for treating cholera 2014 · Cochrane Headline outcomes only
RR 0.23 [0.16, 0.34]
2 studies · 375 participants
Low

Microbiological efficacy ‐ pathogen eradication · patients with chronic bacterial prostatitis

It is very uncertain whether levofloxacin changes microbiological efficacy ‐ pathogen eradication compared with ciprofloxacin (very low certainty).

1 finding from 1 review

Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 1.18 [0.81, 1.71]
2 studies · 669 participants
Very low

Clinical efficacy ‐ cure or improvement at · patients with chronic bacterial prostatitis

Levofloxacin showed no clear difference in clinical efficacy ‐ cure or improvement at end of treatment compared with ciprofloxacin (low certainty).

2 findings from 1 review

Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 1.16 [0.93, 1.46]
2 studies · 669 participants
Low
Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 1.16 [0.86, 1.55]
2 studies · 669 participants
Very low

Adverse effects of treatment ‐ any adverse effects · patients with chronic bacterial prostatitis

Levofloxacin showed no clear difference in adverse effects of treatment ‐ any adverse effects compared with ciprofloxacin (moderate certainty).

1 finding from 1 review

Antimicrobial therapy for chronic bacterial prostatitis 2013 · Cochrane Headline outcomes only
RR 0.86 [0.7, 1.06]
2 studies · 785 participants
Moderate